Several pharmaceutical companies are actively pursuing GLP-1 based therapies for alcohol use disorder (AUD), signalling a growing interest in expanding their use beyond metabolic conditions
Wegovy and similar medicines, which belong to a class of drugs known as GLP-1 receptor agonists, can cost more than US$1,000 per month, and may require extended use to yield significant benefits
Implementing the 3-4 hour eating rule proactively before escalating to 5 mg can prevent sleep problems from developing
The most consistent lipid change observed with GLP-1 therapy is a reduction in triglycerides , typically ranging from 10-20% in clinical studies
As excitement builds around its possibilities, retatrutide may soon become a leading option for individuals looking to manage their weight and improve their overall health
Red Flags Requiring Immediate Physician Contact Any protocol should clearly communicate the symptoms that warrant immediate physician contact rather than waiting for the next scheduled check-in